Relmada Therapeutics, Inc.

MANUFACTURERS LIFE INSURANCE COMPANY, THE RLMD

Report date

6/30/2026

Quarter

2026 Q2

Filed

9/9/2026

Shares

25,027

Value ($000)

173

Weight

0.0%

2020 Q2 - 2026 Q2 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q2	9/9/2026	173	0.0%	25,027	6/30/2026
2023 Q3	11/15/2023	61	0.0%	20,343	9/30/2023
2023 Q2	8/11/2023	50	0.0%	20,343	6/30/2023
2023 Q1	5/15/2023	57	0.0%	25,037	3/31/2023
2022 Q4	8/11/2023	89	0.0%	25,037	12/31/2022
2022 Q3	8/11/2023	1,110	0.0%	30,430	9/30/2022
2022 Q2	8/11/2023	590	0.0%	30,705	6/30/2022
2022 Q1	8/11/2023	379	0.0%	14,206	3/31/2022
2021 Q3	11/12/2021	220	0.0%	8,407	9/30/2021
2021 Q2	8/12/2021	282	0.0%	8,820	6/30/2021
2021 Q1	5/3/2021	292	0.0%	8,307	3/31/2021
2020 Q4	2/12/2021	282	0.0%	8,780	12/31/2020
2020 Q3	11/9/2020	306	0.0%	8,122	9/30/2020
2020 Q2	8/10/2020	350	0.0%	8,122	6/30/2020